American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on June 10, 2025

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …

Historic Executive Order Fast-Tracks ZenaTech’s ZenaDrone Subsidiary Manufacturing and Go-to-Market Plans for Dual-Use Defense and Commercial Drones

Historic Executive Order Fast-Tracks ZenaTech’s ZenaDrone Subsidiary Manufacturing and Go-to-Market Plans for Dual-Use Defense and Commercial Drones

VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and …

2Checkout Will Host the 9th Edition of CommerceNow Event, Inspiring Businesses to Amplify the Way They Sell Online

2Checkout Will Host the 9th Edition of CommerceNow Event, Inspiring Businesses to Amplify the Way They Sell Online

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- 2Checkout, a global leader in payment and commerce solutions for cross-border digital sales, today announces that its highly anticipated 9th edition of CommerceNow, will take place on June 18-19, 2025. The …

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt

Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …

DeepView® System highlighted at the annual British Burn Association conference

DeepView® System highlighted at the annual British Burn Association conference

DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …

Arvo Tech Names Eric Ermie as CEO

Arvo Tech Names Eric Ermie as CEO

COLUMBUS, Ohio, June 10, 2025 (GLOBE NEWSWIRE) -- Arvo Tech, a provider of integrated financial services for small and mid-sized businesses, today announced the appointment of Eric Ermie as Chief Executive Officer. Ermie brings deep experience in scaling …

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer

MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry luminary with more than 40 years of leadership experience in …

Vertex Joins Oracle’s Enhanced PartnerNetwork Program

Vertex Joins Oracle’s Enhanced PartnerNetwork Program

KING OF PRUSSIA, June 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced it has been selected to participate in Oracle’s enhanced partner program at the …

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

Strengthening CMC leadership to prepare for scaled up neflamapimod manufacturing On track to initiate Phase 3 trial of neflamapimod in DLB in mid-2026 following meeting with regulatory authorities BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. ( …

Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

Four-week Phase 2 study to evaluate investigational, once-daily ZORYVE .05% in infants as young as 3 months to less than 2 years with atopic dermatitis Atopic dermatitis impacts 9.6 million children in the United States; up to 60% of children with atopic …

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

Windtree continues its transformation entering the rapidly growing $85 billion US environmental services space Refocused strategy is expected to generate $12 million in revenue over the next 12 months Transaction expected to produce a profitable business …

Tritium Launches TRI-FLEX EV Charging in Europe to Support Next Phase of EU Infrastructure Needs

Tritium Launches TRI-FLEX EV Charging in Europe to Support Next Phase of EU Infrastructure Needs

Gothenburg, June 10, 2025 (GLOBE NEWSWIRE) -- As Europe’s electric vehicle (EV) market continues to grow, its charging infrastructure is not prepared to handle the coming demand. Most analysts expect EVs to have a 40-50% market share in Europe by 2030. An …

AgEagle Aerial Systems Invited for Follow-Up White House Engagement to Discuss Critical FAA Rulemaking for Beyond Visual Line of Sight (BVLOS) Drone Operations

AgEagle Aerial Systems Invited for Follow-Up White House Engagement to Discuss Critical FAA Rulemaking for Beyond Visual Line of Sight (BVLOS) Drone Operations

Second White House engagement invitation highlights AgEagle’s leadership role in shaping critical UAV policy WICHITA, Kan., June 10, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS)(“Company”), a leading provider of unmanned aerial systems …

Blue Square X and Aurora Multimedia Redefine the Conference Room and Classroom with Vision X and ReAX Room

Blue Square X and Aurora Multimedia Redefine the Conference Room and Classroom with Vision X and ReAX Room

ORLANDO, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Blue Square X is partnering with Aurora Multimedia to deliver a groundbreaking meeting room experience at InfoComm 2025. Featured in Booth 2342, the collaboration brings together Blue Square X’s Vision X 163 …

American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report

American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report

Vancouver, BC, June 10, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide an update on its exploration plans and independent technical report (the “Technical …

HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology

HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology

MONTREAL and LYON, France, June 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, and its French …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service